ReviewCureus2026
Muscle Health Before Sarcopenia: A Primary Care Approach to Preserving Strength, Function, and Healthy Longevity From Midlife.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sarcopenia is traditionally framed as a geriatric condition characterized by age-related loss of muscle mass and strength. However, muscle mass, strength, power, and quality follow distinct age-related trajectories, with deterioration in several functional dimensions becoming detectable during midlife and, in some cases, preceding substantial changes in muscle quantity. A predominant focus on established sarcopenia may therefore overlook earlier opportunities to preserve muscle health. This narrative review examines the life-course trajectory of muscle health from midlife, evaluates evidence-based strategies for preserving muscle function, and considers practical opportunities for early identification in primary care. Resistance training is supported by substantial evidence for improving muscle strength, mass, power, and physical function, including evidence of benefit during midlife. Adequate dietary protein intake complements exercise-induced adaptations and may help preserve lean tissue, particularly during intentional weight loss, whereas routine vitamin D supplementation has not demonstrated comparable benefits for muscle outcomes in otherwise healthy adults. Current evidence remains insufficient to support universal muscle-health screening in asymptomatic middle-aged adults. Targeted, opportunistic case-finding may provide a pragmatic alternative in primary care, particularly for individuals with relevant comorbidities, functional concerns, nutritional risk, or periods of physical disuse. Brief assessment may incorporate objective measures such as handgrip strength and the Five Times Sit-to-Stand Test, whereas the relatively low sensitivity of SARC-F (Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls) may limit its utility for detecting subtle functional decline. Muscle-health deterioration is not confined to old age, and midlife represents a clinically relevant window for preserving strength, function, and muscular reserve. Current evidence supports resistance exercise, adequate nutrition, and physical activity as modifiable determinants of muscle health; however, prospective studies are needed to determine whether systematic midlife assessment and early intervention reduce future sarcopenia, disability, or loss of independence and improve long-term healthspan.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.